Morgan Stanley Finance LLC has filed a preliminary pricing supplement for structured investment notes due July 26, 2029, offering investors exposure to the performance of Alphabet Inc. Class A Common Stock, Meta Platforms, Inc. Class A Common Stock, and Microsoft Corporation Common Stock. The notes feature an auto-callable structure with potential early redemption in July 2027 if all three underliers meet specified thresholds, alongside the possibility of upside participation at maturity if all underliers outperform their initial levels. The offering, filed on July 17, 2026, represents a structured product designed for investors willing to forgo current income in exchange for principal repayment and conditional upside exposure.
Key Points
- NYSE: MS-PQ — Morgan Stanley Finance LLC issuing structured notes through July 2029
- Three-underlier jump notes with auto-callable feature linked to worst-performing stock among Alphabet, Meta, and Microsoft
- Early redemption payment of $1,155 per note possible on July 29, 2027, if all underliers close at or above 90% of initial levels on first determination date of July 26, 2027
- Stated principal amount of $1,000 per note with 125% participation rate in upside movement; maturity payment includes principal plus upside if all underliers outperform initial levels
Structured Product Architecture and Underlier Selection
Morgan Stanley Finance LLC has structured these jump notes to track the performance of three major technology stocks: Alphabet Inc. Class A Common Stock, Meta Platforms, Inc. Class A Common Stock, and Microsoft Corporation Common Stock. The product supplement filing discloses that the notes' value is explicitly determined by the worst-performing underlier among the three, meaning that strong performance by two stocks cannot offset weakness in the third. This design choice means that investors do not receive asset diversification benefits from exposure to multiple underliers; instead, poor performance by any single stock adversely affects returns on the notes regardless of how the other two stocks perform.
The strike date for initial level determination is July 22, 2026, with the pricing date also occurring on July 22, 2026. The filing does not disclose the specific initial levels for each of the three stocks, stating instead that these levels represent the closing level on the strike date for each respective underlier. The notes have a stated principal amount of $1,000 per note, with an original issue date of July 27, 2026. Investors purchasing the notes are required to hold them in fee-based advisory accounts, a restriction noted in the commission and pricing table within the document.
Auto-Callable Redemption Mechanics and Early Exit Opportunity
The notes incorporate an automatic early redemption feature that becomes relevant on the first determination date of July 26, 2027. If the closing level of each of the three underliers is greater than or equal to its respective call threshold level on that date, the notes will be automatically redeemed for an early redemption payment of $1,155 per note on July 29, 2027. The filing specifies that the call threshold level for each underlier is set at 90% of its initial level, though the specific dollar amounts for these thresholds are not disclosed in the available excerpt of the pricing supplement.
The automatic redemption feature means no further payments will be made on the notes once they have been automatically redeemed. This structure creates a potential point of capital return within approximately one year of the original issue date, contingent on all three underliers maintaining at least 90% of their initial values. The filing emphasizes that investors should understand this notes will be called away if the conditions are met, limiting their ability to retain exposure to the underliers should performance meet the redemption threshold.
Maturity Payment Structure and Participation Rate
If the notes have not been automatically redeemed prior to maturity on July 26, 2029, investors will receive payment determined by the performance of the worst-performing underlier. The filing discloses that if the final level of each underlier is greater than its initial level, investors receive the stated principal amount of $1,000 plus an upside payment. However, if the final level of any underlier is equal to or less than its initial level, investors receive only the stated principal amount at maturity. This binary outcome—full principal repayment with no upside participation if any underlier fails to outperform—reflects the worst-performing underlier design.
The upside payment is calculated using a 125% participation rate, which the filing defines as: stated principal amount multiplied by the participation rate multiplied by the underlier percent change of the worst performing underlier. The underlier percent change for each stock is calculated as (final level minus initial level) divided by initial level. This means investors receive 125% of the percentage gain experienced by the worst-performing stock, applied to the $1,000 principal. The filing notes that closing levels and adjustment factors are defined in the accompanying product supplement and that calculated levels are rounded to three decimal places as necessary.
Valuation and Embedded Costs at Issuance
The filing discloses that the estimated value of the notes on the pricing date is approximately $974.80 per note, or within $30.00 of that estimate. This valuation represents a material discount to the $1,000 original issue price, reflecting the costs associated with issuing, selling, structuring, and hedging the notes, which are borne by investors. The company's own pricing and valuation models, market inputs, and assumptions relating to the underliers, instruments based on the underliers, volatility, and current and expected interest rates all factor into this estimated value determination.
Morgan Stanley disclosed that in determining the economic terms of the notes, it uses an internal funding rate that is likely to be lower than its secondary market credit spreads, a structure advantageous to the issuer. The filing explicitly states that if the issuing, selling, structuring, and hedging costs borne by investors were lower or if the internal funding rate were higher, one or more of the economic terms of the notes would be more favorable to investors. This transparency regarding the valuation methodology and cost allocation provides context for understanding the gap between estimated value and issue price.
Commission Structure and Distribution Arrangement
The filing indicates that Morgan Stanley & Co. LLC, an affiliate of Morgan Stanley Finance LLC and a wholly-owned subsidiary of Morgan Stanley, serves as the agent for the offering. According to the disclosure, MS & Co. expects to sell all of the notes it purchases from Morgan Stanley Finance LLC to an unaffiliated dealer at a specified price per note, with further sale to certain fee-based advisory accounts at the public price of $1,000 per note. The filing states that MS & Co. will not receive a sales commission with respect to the notes, departing from a traditional commission structure.
Specific agent commissions and fees and proceeds to the issuer are indicated in the commission table but are not completed in the preliminary pricing supplement, with those figures to be filled in on the final pricing supplement. The notes will be sold exclusively to investors purchasing in fee-based advisory accounts, a distribution limitation that narrows the investor pool to advisory clients operating under fee-based arrangements rather than commission-based compensation models.
Guarantee and Credit Risk Considerations
Morgan Stanley fully and unconditionally guarantees the obligations of Morgan Stanley Finance LLC with respect to these notes. However, the filing makes clear that the notes are unsecured obligations with no security interest in or access to any underlying reference asset. All payments on the notes are explicitly subject to Morgan Stanley's credit risk, and investors could lose some or all of their investment if Morgan Stanley defaults on its obligations. The filing emphasizes that these notes are not deposits or savings accounts and are not insured by the Federal Deposit Insurance Corporation or any other governmental agency or instrumentality, nor are they obligations of, or guaranteed by, a bank.
The unsecured nature of the notes combined with their dependence on Morgan Stanley's creditworthiness creates credit exposure distinct from the market risk linked to the three underlier stocks. Investors evaluating these notes must assess both the probability of movements in Alphabet, Meta, and Microsoft stock prices and Morgan Stanley's ability to meet its payment obligations through the maturity date of July 26, 2029.
Intended Investor Profile and Risk Disclosure
The filing states that the notes are designed for investors who are concerned about principal risk and who are willing to forgo current income in exchange for the repayment of principal at maturity and the possibility of receiving an early redemption payment or payment at maturity that exceeds the stated principal amount. By definition, these notes pay no interest and offer no current income stream, focusing instead on potential principal return and conditional upside appreciation. The structured product is not suitable for income-focused investors and carries complexity that requires careful evaluation of the auto-callable feature, worst-performing underlier mechanism, and participation rate.
The filing explicitly warns that the fact that the notes are linked to more than one underlier does not provide asset diversification benefits. Instead, poor performance by any single underlier will adversely affect returns regardless of the performance of the other underliers. This characterization of the worst-performing underlier structure as a concentration risk rather than a diversification opportunity is critical for investor understanding. The document notes that the notes involve risks not associated with an investment in ordinary debt securities and directs investors to the risk factors section beginning on page 6 of the document for detailed risk disclosure.
Registration, Listing Status, and Document References
The pricing supplement is filed pursuant to Rule 424(b)(2) under the Securities Act of 1933 and references registration statement numbers 333-293641 and 333-293641-01. The notes are issued as part of Morgan Stanley Finance LLC's Series A Global Medium-Term Notes program, a framework allowing the issuer to conduct multiple structured product offerings. The CUSIP number for the notes is 61781GM81, and the ISIN is US61781GM813. The filing specifies that the notes will not be listed on any securities exchange, meaning they will trade only in the over-the-counter market, if at all.
The pricing supplement is dated July 17, 2026, and references accompanying product supplement, tax supplement, and prospectus documents all dated April 8, 2026. Investors are directed to read the preliminary pricing supplement together with the related product supplement, tax supplement, and prospectus. The SEC and state securities regulators have not approved or disapproved the notes or determined the truthfulness or completeness of the documents, with any representation to the contrary constituting a criminal offense.
Final Determination Date and Maturity Timeline
The final determination date for assessing whether the notes will receive upside payment at maturity is July 23, 2029, subject to postponement for non-trading days and certain market disruption events. This date, falling three days before the maturity date of July 26, 2029, represents the reference point at which closing levels of each underlier will be measured to determine the final payment to investors. The three-year investment horizon from the original issue date of July 27, 2026, to maturity on July 26, 2029, provides investors with a defined investment period, though the potential for early redemption on July 29, 2027, could shorten the actual holding period.
The postponement provisions for non-trading days and market disruption events mean that the determination dates may shift if market conditions warrant adjustment. These provisions protect the issuer and investors from determinations occurring on dates when normal market trading cannot occur, ensuring that the closing levels used for payment calculations reflect actual market activity.




Please wait processing your request...